Koichi Wakabayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Koichi Wakabayashi has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Fumiaki Mori
Hirosaki University Graduate School of Medicine
10 shared publicationsHitoshi Takahashi
University of Niigata
9 shared publicationsKunikazu Tanji
Hirosaki University Graduate School of Medicine
3 shared publicationsMakoto Nishie
Department of Neuropathology, Institute of Brain Science, Hirosaki University School of Medicine, Hirosaki, Japan
3 shared publicationsMakoto Yoshimoto
Molecular Biology Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical, Saitama, Japan
3 shared publications- Yasuo Miki
Department of Neuropathology, Biomedical Research Center, Hirosaki University Graduate School of Medicine , Hirosaki
3 shared publications
Latest Publications
- Open Access
- 14 December 2014
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 2 (1) , 173
Analysis of microRNA from archived formalin-fixed paraffin-embedded specimens of amyotrophic lateral sclerosis
MicroRNAs (miRNAs) are noncoding small RNAs that regulate gene expression. This study investigated whether formalin-fixed paraffin-embedded (FFPE) specimens from postmortem cases of neurodegenerative disorders would be suitable for miRNA profiling. Ten FFPE samples from 6 cases of amyotrophic lateral sclerosis (ALS) and 4 neurologically normal controls were selected for miRNA analysis on the basis of the following criteria for RNA quality: (i) a postmortem interval of less than 6 hours, (ii) a formalin fixation time of less than 4 weeks, (iii) an RNA yield per sample of more than 500 ng, and (iv) sufficient quality of the RNA agarose gel image. An overall RNA extraction success rate was 46.2%. For ALS, a total of 364 miRNAs were identified in the motor cortex, 91 being up-regulated and 233 down-regulated. Target genes were predicted using miRNA bioinformatics software, and the data applied to ontology analysis. This indicated that one of the miRNAs up-regulated in ALS (miR-338-3p) had already been identified in leukocytes, serum, cerebrospinal fluid and frozen spinal cord from ALS patients. Although analysis was possible for just under half of the specimens examined, we were able to show that informative miRNA data can be derived from archived FFPE samples from postmortem cases of neurodegenerative disorders.
- 14 December 2014
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 2 (1) , 173
Open AccessAnalysis of microRNA from archived formalin-fixed paraffin-embedded specimens of amyotrophic lateral sclerosis
MicroRNAs (miRNAs) are noncoding small RNAs that regulate gene expression. This study investigated whether formalin-fixed paraffin-embedded (FFPE) specimens from postmortem cases of neurodegenerative disorders would be suitable for miRNA profiling. Ten FFPE samples from 6 cases of amyotrophic lateral sclerosis (ALS) and 4 neurologically normal controls were selected for miRNA analysis on the basis of the following criteria for RNA quality: (i) a postmortem interval of less than 6 hours, (ii) a formalin fixation time of less than 4 weeks, (iii) an RNA yield per sample of more than 500 ng, and (iv) sufficient quality of the RNA agarose gel image. An overall RNA extraction success rate was 46.2%. For ALS, a total of 364 miRNAs were identified in the motor cortex, 91 being up-regulated and 233 down-regulated. Target genes were predicted using miRNA bioinformatics software, and the data applied to ontology analysis. This indicated that one of the miRNAs up-regulated in ALS (miR-338-3p) had already been identified in leukocytes, serum, cerebrospinal fluid and frozen spinal cord from ALS patients. Although analysis was possible for just under half of the specimens examined, we were able to show that informative miRNA data can be derived from archived FFPE samples from postmortem cases of neurodegenerative disorders.
- Open Access
- 3 May 2014
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 2 (1) , 1-14
Phosphorylation of serine 349 of p62 in Alzheimer’s disease brain
Extensive research on p62 has established its role in oxidative stress, protein degradation and in several diseases such as Paget’s disease of the bone, frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Importantly, previous studies showed that p62 binds directly to Keap1, which is a ubiquitin E3 ligase responsible for degrading Nrf2. Indeed, colocalisation of p62 and Keap1 occurs in tumorigenesis and neurodegeneration. A serine (S) residue in the Keap1-interacting region of p62 is phosphorylated in hepatocellular carcinoma, and this phosphorylation contributes to tumour growth through the higher affinity of p62 to Keap1. However, it remains largely unknown whether p62 is phosphorylated in the Keap1-interacting region under neurodegenerative conditions. To answer this question, we generated an antibody against phosphorylated S349 (P-S349) of p62 and showed that S349 is phosphorylated following disruption of protein degradation. In particular, the ratio of P-S349 to total p62 levels was significantly increased in the brains with Alzheimer’s disease (AD) compared with controls. We also compared the reactivity of the P-S349 antibody with P-S403 of p62 and showed that these two phosphorylated sites on p62 cause different responses with proteasome inhibition and show distinct localisation patterns in AD brains. In addition to disruption of protein degradation systems, activation of oxidative stress can induce P-S349. These results support the hypothesis that disruption of protein degradation systems and sustained activation of the Keap1-Nrf2 system occur in the brains with AD.
- 3 May 2014
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 2 (1) , 1-14
Open AccessPhosphorylation of serine 349 of p62 in Alzheimer’s disease brain
Extensive research on p62 has established its role in oxidative stress, protein degradation and in several diseases such as Paget’s disease of the bone, frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Importantly, previous studies showed that p62 binds directly to Keap1, which is a ubiquitin E3 ligase responsible for degrading Nrf2. Indeed, colocalisation of p62 and Keap1 occurs in tumorigenesis and neurodegeneration. A serine (S) residue in the Keap1-interacting region of p62 is phosphorylated in hepatocellular carcinoma, and this phosphorylation contributes to tumour growth through the higher affinity of p62 to Keap1. However, it remains largely unknown whether p62 is phosphorylated in the Keap1-interacting region under neurodegenerative conditions. To answer this question, we generated an antibody against phosphorylated S349 (P-S349) of p62 and showed that S349 is phosphorylated following disruption of protein degradation. In particular, the ratio of P-S349 to total p62 levels was significantly increased in the brains with Alzheimer’s disease (AD) compared with controls. We also compared the reactivity of the P-S349 antibody with P-S403 of p62 and showed that these two phosphorylated sites on p62 cause different responses with proteasome inhibition and show distinct localisation patterns in AD brains. In addition to disruption of protein degradation systems, activation of oxidative stress can induce P-S349. These results support the hypothesis that disruption of protein degradation systems and sustained activation of the Keap1-Nrf2 system occur in the brains with AD.
- 1 December 2013
- Vol. 65 (12) , 1433-44
[Deposition and clearance of β-amyloid in the brain].
Amyloid β-protein (Aβ) is deposited as senile plaques and vascular amyloid in the brain of patients with Alzheimer's disease as well as in a significant proportion of non-demented elderly individuals. Microglia play critical roles in the uptake and proteolytic clearance of both the soluble and fibrillary forms of Aβ. Astrocytes separate fibrillary Aβ from neurons by extending hypertrophic processes and internalizing the Aβ into endosomes/lysosomes, suggesting their role in the degradation of Aβ. Recent studies have shown that perivascular clearance of Aβ is a two-step process, involving (i) the uptake of Aβ by glia limitans astrocytes and (ii) perivascular or transendothelial clearance after their secretion into the perivascular space.
- 1 December 2013
- Vol. 65 (12) , 1433-44
[Deposition and clearance of β-amyloid in the brain].
Amyloid β-protein (Aβ) is deposited as senile plaques and vascular amyloid in the brain of patients with Alzheimer's disease as well as in a significant proportion of non-demented elderly individuals. Microglia play critical roles in the uptake and proteolytic clearance of both the soluble and fibrillary forms of Aβ. Astrocytes separate fibrillary Aβ from neurons by extending hypertrophic processes and internalizing the Aβ into endosomes/lysosomes, suggesting their role in the degradation of Aβ. Recent studies have shown that perivascular clearance of Aβ is a two-step process, involving (i) the uptake of Aβ by glia limitans astrocytes and (ii) perivascular or transendothelial clearance after their secretion into the perivascular space.
- 1 January 2013
- Vol. 65 (1) , 9-18
[Pathology of corticobasal syndrome].
Focal asymmetric cortical atrophy with ballooned neurons, nigral degeneration, and tau-positive neuronal and glial lesions in both the gray and white matter, particularly astrocytic plaques in the affected cerebral cortex, are characteristic features of corticobasal degeneration (CBD). Since the clinical manifestations of CBD are diverse, several neurological diseases can present with clinical findings that are thought to be specific to CBD. These clinical conditions are referred to as corticobasal syndrome (CBS). CBS includes Alzheimer's disease, progressive supranuclear palsy, Pick's disease, Lewy body disease, frontotemporal lobar degeneration, and Creutzfeldt-Jakob disease. In cases of clinically diagnosed CBS, the consistent histopathological finding appears to be asymmetric frontal and parietal cortical degeneration.
- 1 January 2013
- Vol. 65 (1) , 9-18
[Pathology of corticobasal syndrome].
Focal asymmetric cortical atrophy with ballooned neurons, nigral degeneration, and tau-positive neuronal and glial lesions in both the gray and white matter, particularly astrocytic plaques in the affected cerebral cortex, are characteristic features of corticobasal degeneration (CBD). Since the clinical manifestations of CBD are diverse, several neurological diseases can present with clinical findings that are thought to be specific to CBD. These clinical conditions are referred to as corticobasal syndrome (CBS). CBS includes Alzheimer's disease, progressive supranuclear palsy, Pick's disease, Lewy body disease, frontotemporal lobar degeneration, and Creutzfeldt-Jakob disease. In cases of clinically diagnosed CBS, the consistent histopathological finding appears to be asymmetric frontal and parietal cortical degeneration.
- Top Cited Papers
- 24 May 2012
- Published by Springer Nature in Molecular Neurobiology
- Vol. 47 (2) , 495-508
The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
The histopathological hallmark of Parkinson’s disease (PD) is the presence of fibrillar aggregates referred to as Lewy bodies (LBs), in which α-synuclein is a major constituent. Pale bodies, the precursors of LBs, may serve the material for that LBs continue to expand. LBs consist of a heterogeneous mixture of more than 90 molecules, including PD-linked gene products (α-synuclein, DJ-1, LRRK2, parkin, and PINK-1), mitochondria-related proteins, and molecules implicated in the ubiquitin–proteasome system, autophagy, and aggresome formation. LB formation has been considered to be a marker for neuronal degeneration because neuronal loss is found in the predilection sites for LBs. However, recent studies have indicated that nonfibrillar α-synuclein is cytotoxic and that fibrillar aggregates of α-synuclein (LBs and pale bodies) may represent a cytoprotective mechanism in PD.
- 24 May 2012
- Published by Springer Nature in Molecular Neurobiology
- Vol. 47 (2) , 495-508
Top Cited PapersThe Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
The histopathological hallmark of Parkinson’s disease (PD) is the presence of fibrillar aggregates referred to as Lewy bodies (LBs), in which α-synuclein is a major constituent. Pale bodies, the precursors of LBs, may serve the material for that LBs continue to expand. LBs consist of a heterogeneous mixture of more than 90 molecules, including PD-linked gene products (α-synuclein, DJ-1, LRRK2, parkin, and PINK-1), mitochondria-related proteins, and molecules implicated in the ubiquitin–proteasome system, autophagy, and aggresome formation. LB formation has been considered to be a marker for neuronal degeneration because neuronal loss is found in the predilection sites for LBs. However, recent studies have indicated that nonfibrillar α-synuclein is cytotoxic and that fibrillar aggregates of α-synuclein (LBs and pale bodies) may represent a cytoprotective mechanism in PD.
- 9 June 2010
- Published by Springer Nature in Acta Neuropathologica
- Vol. 120 (1) , 1-12
Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain
Involvement of the peripheral nervous system (PNS) is relatively common in some neurodegenerative proteinopathies of the brain and may be pathogenetically and diagnostically important. In Parkinson’s disease, neuronal α-synuclein aggregates are distributed throughout the nervous system, including the central nervous system (CNS), sympathetic ganglia, enteric nervous system, cardiac and pelvic plexuses, submandibular gland, adrenal medulla and skin. The pathological process may target the PNS and CNS at the same time. In multiple system atrophy, numerous glial cytoplasmic inclusions composed of filamentous α-synuclein are widely distributed in the CNS, while α-synuclein accumulation is minimal in the sympathetic ganglia and is restricted to neurons. Neurofibrillary tangles can occur in the sympathetic and spinal ganglia in tauopathy, although they appear to develop independently of cerebral Alzheimer’s disease pathology. In amyotrophic lateral sclerosis, neuronal loss with TDP-43-positive neuronal cytoplasmic inclusions in the spinal ganglia is more frequent than previously thought. Peripheral ganglia and visceral organs are also involved in polyglutamine diseases. Further elucidation and characterization of PNS lesions will have implications for intravital biopsy diagnosis in neurodegenerative proteinopathy, particularly in Parkinson’s disease.
- 9 June 2010
- Published by Springer Nature in Acta Neuropathologica
- Vol. 120 (1) , 1-12
Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain
Involvement of the peripheral nervous system (PNS) is relatively common in some neurodegenerative proteinopathies of the brain and may be pathogenetically and diagnostically important. In Parkinson’s disease, neuronal α-synuclein aggregates are distributed throughout the nervous system, including the central nervous system (CNS), sympathetic ganglia, enteric nervous system, cardiac and pelvic plexuses, submandibular gland, adrenal medulla and skin. The pathological process may target the PNS and CNS at the same time. In multiple system atrophy, numerous glial cytoplasmic inclusions composed of filamentous α-synuclein are widely distributed in the CNS, while α-synuclein accumulation is minimal in the sympathetic ganglia and is restricted to neurons. Neurofibrillary tangles can occur in the sympathetic and spinal ganglia in tauopathy, although they appear to develop independently of cerebral Alzheimer’s disease pathology. In amyotrophic lateral sclerosis, neuronal loss with TDP-43-positive neuronal cytoplasmic inclusions in the spinal ganglia is more frequent than previously thought. Peripheral ganglia and visceral organs are also involved in polyglutamine diseases. Further elucidation and characterization of PNS lesions will have implications for intravital biopsy diagnosis in neurodegenerative proteinopathy, particularly in Parkinson’s disease.
- 18 September 2007
- Published by Wiley in Neuropathology
- Vol. 27 (5) , 494-506
The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
The histological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates called Lewy bodies (LBs). LB formation has been considered to be a marker for neuronal degeneration, because neuronal loss is found in the predilection sites for LBs. To date, more than 70 molecules have been identified in LBs, in which α‐synuclein is a major constituent of LB fibrils. α‐synuclein immunohistochemistry reveals that diffuse cytoplasmic staining develops into pale bodies via compaction, and that LBs arise from the peripheral portion of pale bodies. This α‐synuclein abnormality is found in 10% of pigmented neurons in the substantia nigra and more than 50% of those in the locus ceruleus in PD. Recent studies have suggested that oligomers and protofibrils of α‐synuclein are cytotoxic, and that LBs may represent a cytoprotective mechanism in PD.
- 18 September 2007
- Published by Wiley in Neuropathology
- Vol. 27 (5) , 494-506
The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
The histological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates called Lewy bodies (LBs). LB formation has been considered to be a marker for neuronal degeneration, because neuronal loss is found in the predilection sites for LBs. To date, more than 70 molecules have been identified in LBs, in which α‐synuclein is a major constituent of LB fibrils. α‐synuclein immunohistochemistry reveals that diffuse cytoplasmic staining develops into pale bodies via compaction, and that LBs arise from the peripheral portion of pale bodies. This α‐synuclein abnormality is found in 10% of pigmented neurons in the substantia nigra and more than 50% of those in the locus ceruleus in PD. Recent studies have suggested that oligomers and protofibrils of α‐synuclein are cytotoxic, and that LBs may represent a cytoprotective mechanism in PD.
- 19 July 2007
- Published by Wiley in Neuropathology
- Vol. 27 (4) , 390-395
Miliary brain metastasis presenting with dementia: Progression pattern of cancer metastases in the cerebral cortex
We report an autopsy case of an 82‐year‐old woman with progressive dementia due to miliary brain metastasis from lung adenocarcinoma. The patient presented with dementia 5 months prior to death and suddenly died of pulmonary hemorrhage. Postmortem examination revealed normal appearance of the brain. However, there were numerous foci of cancer metastasis in all parts of the brain on light microscopic examination. The carcinoma cells were located in the perivascular (Virchow‐Robin) space and did not invade to the brain parenchyma. The carcinoma cells were also found in the subpial space. In the cerebral cortex, foci of metastasis appeared to spread in the following way: tiny foci of metastasis initially occur in the middle cortical layer, then spread to all layers through the perivascular space, and finally reach the subpial space and subcortical white matter. Although the junction between gray and white matter is a preferred site for usual brain metastasis, middle cortical layer was considered to be the initial site for metastasis in our patient. The perivascular pial sheath plays an important role for the development of miliary brain metastasis.
- 19 July 2007
- Published by Wiley in Neuropathology
- Vol. 27 (4) , 390-395
Miliary brain metastasis presenting with dementia: Progression pattern of cancer metastases in the cerebral cortex
We report an autopsy case of an 82‐year‐old woman with progressive dementia due to miliary brain metastasis from lung adenocarcinoma. The patient presented with dementia 5 months prior to death and suddenly died of pulmonary hemorrhage. Postmortem examination revealed normal appearance of the brain. However, there were numerous foci of cancer metastasis in all parts of the brain on light microscopic examination. The carcinoma cells were located in the perivascular (Virchow‐Robin) space and did not invade to the brain parenchyma. The carcinoma cells were also found in the subpial space. In the cerebral cortex, foci of metastasis appeared to spread in the following way: tiny foci of metastasis initially occur in the middle cortical layer, then spread to all layers through the perivascular space, and finally reach the subpial space and subcortical white matter. Although the junction between gray and white matter is a preferred site for usual brain metastasis, middle cortical layer was considered to be the initial site for metastasis in our patient. The perivascular pial sheath plays an important role for the development of miliary brain metastasis.
- 20 July 2006
- Published by Wiley in Neuropathology
- Vol. 26 (4) , 338-345
Cellular pathology in multiple system atrophy
Multiple system atrophy (MSA) is a sporadic, adult‐onset neurodegenerative disease, which is characterized by striatonigral degeneration, olivopontocerebellar atrophy, and preganglionic autonomic lesions in any combination. The histological hallmark is the presence of argyrophilic fibrillary inclusions in the oligodendrocytes, referred to as glial cytoplasmic inclusions (GCIs). Fibrillary inclusions are also found in the neuronal somata, axons, and nucleus. Neuronal cytoplasmic inclusions are frequently found in the pontine and inferior olivary nuclei. Since the discovery of α‐synuclein as a major component of glial and neuronal inclusions in MSA, two neurodegenerative processes have been considered in this disease: one is due to the widespread occurrence of GCIs associated with oligodendroglia–myelin degeneration (oligodendrogliopathy) in the central nervous system, and the other is due to the filamentous aggregation of α‐synuclein in the neurons in several brain regions. These two degenerative processes might synergistically cause neuronal depletion in MSA.
- 20 July 2006
- Published by Wiley in Neuropathology
- Vol. 26 (4) , 338-345
Cellular pathology in multiple system atrophy
Multiple system atrophy (MSA) is a sporadic, adult‐onset neurodegenerative disease, which is characterized by striatonigral degeneration, olivopontocerebellar atrophy, and preganglionic autonomic lesions in any combination. The histological hallmark is the presence of argyrophilic fibrillary inclusions in the oligodendrocytes, referred to as glial cytoplasmic inclusions (GCIs). Fibrillary inclusions are also found in the neuronal somata, axons, and nucleus. Neuronal cytoplasmic inclusions are frequently found in the pontine and inferior olivary nuclei. Since the discovery of α‐synuclein as a major component of glial and neuronal inclusions in MSA, two neurodegenerative processes have been considered in this disease: one is due to the widespread occurrence of GCIs associated with oligodendroglia–myelin degeneration (oligodendrogliopathy) in the central nervous system, and the other is due to the filamentous aggregation of α‐synuclein in the neurons in several brain regions. These two degenerative processes might synergistically cause neuronal depletion in MSA.
- 23 January 2006
- Published by Wiley in Neuropathology
- Vol. 26 (1) , 62-65
Oligodendrocytes within astrocytes (“emperipolesis”) in the cerebral white matter in hepatic and hypoglycemic encephalopathy
We report the occurrence of oligodendrocytes within astrocytes (“emperipolesis”) in two autopsy cases of metabolic encephalopathy: one patient with hepatic encephalopathy due to citrullinemia who suffered recurrent unconsciousness (clinical duration, 32 months) and another with hypoglycemic encephalopathy who lapsed into a persistent vegetative state (clinical duration, 22 months). In both cases, hypertrophic astrocytes were found to have engulfed one to several oligodendrocytes in the devastated cerebral white matter. Previous studies have reported that emperipolesis occurs in various CNS diseases showing destruction of myelin or inflammation of the white matter, including multiple sclerosis, cerebral infarct and CJD. The present findings suggest that emperipolesis can occur even in chronic metabolic disorders that extensively involve the cerebral white matter.
- 23 January 2006
- Published by Wiley in Neuropathology
- Vol. 26 (1) , 62-65
Oligodendrocytes within astrocytes (“emperipolesis”) in the cerebral white matter in hepatic and hypoglycemic encephalopathy
We report the occurrence of oligodendrocytes within astrocytes (“emperipolesis”) in two autopsy cases of metabolic encephalopathy: one patient with hepatic encephalopathy due to citrullinemia who suffered recurrent unconsciousness (clinical duration, 32 months) and another with hypoglycemic encephalopathy who lapsed into a persistent vegetative state (clinical duration, 22 months). In both cases, hypertrophic astrocytes were found to have engulfed one to several oligodendrocytes in the devastated cerebral white matter. Previous studies have reported that emperipolesis occurs in various CNS diseases showing destruction of myelin or inflammation of the white matter, including multiple sclerosis, cerebral infarct and CJD. The present findings suggest that emperipolesis can occur even in chronic metabolic disorders that extensively involve the cerebral white matter.